Matthew Keller

Stock Analyst at HC Wainwright & Co.

(2.41)

# 2,443

Out of 4,944 analysts

2

Total ratings

100%

Success rate

10.78%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Matthew Keller

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ACXP Acurx Pharmaceuticals	Maintains: Buy	$8 → $31	$4.67	+563.95%	1	Aug 12, 2025
	FGEN FibroGen	Maintains: Buy	$10 → $43	$9.38	+358.42%	1	Aug 7, 2025

Acurx Pharmaceuticals

Aug 12, 2025

Maintains: Buy

Price Target: $8 → $31

Current: $4.67

Upside: +563.95%

FibroGen

Aug 7, 2025

Maintains: Buy

Price Target: $10 → $43

Current: $9.38

Upside: +358.42%